{
    "nctId": "NCT04583124",
    "briefTitle": "Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)",
    "officialTitle": "Neurotoxicity Prevention With a Multimodal Program (ATENTO) Prior to Cancer Treatment Versus Throughout Cancer Treatment in Women Newly Diagnosed for Breast Cancer: a Randomized Clinical Trial.",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 56,
    "primaryOutcomeMeasure": "Quality of life (QLQ)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* To have 18 years or older\n* To have a breast cancer diagnosis (Stage I-III)\n* To be on waiting list for medical adjuvant treatment with risk of central and/or peripheral neurotoxicity.\n* To have signed the informed consent.\n* To have medical clearance for participation.\n\nExclusion Criteria:\n\n* To have a previous history of cancer or any cancer treatment.\n* Pregnant patients.\n* To participate in another intervention that could influence on the outcomes.\n* To have a neurodegenerative disease that affects central or peripheral nervous system and could influence the results.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}